Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How Has The Benign Prostatic Hyperplasia Treatment Market Size Shifted, And What Is the Outlook Through 2034?
In recent times, the market for benign prostatic hyperplasia treatment has seen a significant expansion. The market, which was $8.23 billion strong in 2024, is forecasted to increase to $8.71 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.9%. The historical growth can be linked to heightened awareness and screening measures, a rising rate of BPH incidence, growing consciousness about healthcare, enhancement of healthcare infrastructure, and an escalating aging population.
Expectations are high for significant expansion in the benign prostatic hyperplasia treatment market in the coming years. The predicted value for this market by 2029 is $10.83 billion, growing at a compound annual growth rate (CAGR) of 5.6%. Several factors contribute to this growth, including increasing inclination towards minimally invasive surgical procedures, an aging population, enhanced accessibility to state-of-the-art treatment alternatives, an amplified focus on providing patient-oriented care, along with a rising incidence of coexisting diseases. Looking ahead, the market trends forecasted consist of the evolution of focused therapies, the incorporation of digital healthcare services, advancements in surgical techniques, the use of 3D imaging for diagnosis, and progression in patient-focused care models.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21112&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Benign Prostatic Hyperplasia Treatment Market?
The benign prostatic hyperplasia treatment market is set for growth, fuelled by the increasing adoption of minimally invasive surgeries. These procedures involve minimal or no incisions, utilizing specialized instruments, which consequently lower recovery time, pain, and risk of complications. The growing preference for minimally invasive surgeries can be attributed to advantages like shorter recovery periods, less pain, a lower chance of complications, and better cosmetic results. Applying these procedures in benign prostatic hyperplasia treatment results in shorter recovery periods, decreased complications, and effective symptom relief, thus improving overall surgical outcomes. As an illustration, the American Society of Plastic Surgeons (ASPS), a professional association based in the US, noted that in 2022, there were 23,672,269 cosmetic minimally invasive procedures conducted worldwide. These included treatments such as neuromodulator injections, lip augmentation, and non-invasive skin tightening. The growing popularity of minimally invasive surgeries, therefore, is propelling the growth of the benign prostatic hyperplasia treatment market.
Which Key Market Segments Comprise the Benign Prostatic Hyperplasia Treatment Market and Drive Its Revenue Growth?
The benign prostatic hyperplasia treatment market covered in this report is segmented –
1) By Treatment: Minimal Invasive Surgery, Invasive Surgery
2) By Therapeutic Class: Alpha Blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Other Therapeutic classes
3) By End User: Home Healthcare, Hospitals And Clinics, Research And Manufacturing
Subsegments:
1) By Minimal Invasive Surgery: Transurethral Resection of the Prostate (TURP), Laser Surgery, Prostatic Urethral Lift, Transurethral Incision of the Prostate (TUIP), Microwave Therapy
2) By Invasive Surgery: Open Prostatectomy, Robotic Prostatectomy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21112&type=smp
Which Areas Are Leading Regions in the Benign Prostatic Hyperplasia Treatment Market Expansion Across the Globe?
North America was the largest region in the benign prostatic hyperplasia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the benign prostatic hyperplasia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Strategic Trends Steering theBenign Prostatic Hyperplasia Treatment Market Direction?
Leading businesses in the benign prostatic hyperplasia treatment arena are focusing their efforts on creating innovative treatments, particularly minimally invasive procedures, to improve patient results and reduce recovery periods. These procedures require either tiny or no cuts, thereby reducing trauma, pain, and possible complications while also speeding up recovery compared to conventional surgical techniques. For instance, in December 2022, Teleflex Incorporated, a US medical device firm, introduced the UroLift System for dealing with benign prostatic hyperplasia. The system makes use of tiny permanent implants to shift enlarged prostate tissue, providing notable relief from symptoms without necessitating tissue removal, cutting, or heating. This outpatient therapy ensures quick recovery, maintains sexual functionality, and offers superior symptom relief compared to traditional BPH drugs, with the side effects typically subsiding within two to four weeks.
View the full report here:
How Is the Benign Prostatic Hyperplasia Treatment Market Conceptually Defined?
Benign prostatic hyperplasia (BPH) treatment refers to medical, minimally invasive, and surgical approaches used to manage the symptoms of an enlarged prostate. BPH is a common condition in aging men, leading to urinary issues such as frequent urination, weak stream, and incomplete bladder emptying.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21112
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
